PINL:GRPOF - Post by User
Post by
Opportunity44on Mar 08, 2017 10:12am
166 Views
Post# 25949910
PPP002
PPP002 It's also mentioned here. All anyone has to do is look it's easy to find.
TBP has a strong pipeline of cannabis sativa based prescription drugs. The Company’s key product is PPP001 which is a medical marijuana product that the Company is developing as a prescription controlled drug for inhalation using a fully assembled titanium pipe. In addition to PPP001, the Company is pursuing a number of other clinical programs designed to leverage the botanical rather than a synthetic. Its PPP002 program is a Phase III botanical drug that is targeting insomnia in chronic pain patients, while its PPP003 is a combination oral product designed to treat chronic pain, PTSD, and neurological conditions. The Company also has a strong pipeline of natural health products that includes AGT001, a topical product for pain management; AGT002 product lineoral for cardiovascular disease prevention, athletic performance, and wellbeing; AGT003 product line for skin care; AGT004 for womenquality of life.